Your browser doesn't support javascript.
loading
Impact of emergency department management of atrial fibrillation with amiodarone on length of stay. A propensity score analysis based on the URGFAICS registry.
Cabello, Irene; Jacob, Javier; Arranz, María; Yuguero, Oriol; Guzman, Jorge; Moreno-Pena, Anna; Frances, Paloma; Santos, Julia; Esquerrà, Anna; Mòdol, Josep-María.
Afiliación
  • Cabello I; Emergency Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat.
  • Jacob J; Emergency Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat.
  • Arranz M; Emergency Department, Hospital de Viladecans, Barcelona.
  • Yuguero O; Emergency Department, Hospital Arnau de Vilanova, Lleida.
  • Guzman J; Emergency Department, Hospital Universitari Joan XXIII de Tarragona, Tarragona.
  • Moreno-Pena A; Emergency Department, Hospital Arnau de Vilanova, Lleida.
  • Frances P; Emergency Department, Hospital Universitari Joan XXIII de Tarragona, Tarragona.
  • Santos J; Emergency Department, Hospital de Viladecans, Barcelona.
  • Esquerrà A; Emergency Department, Hospital Universitari Germans Trias i Pujol de Badalona, Barcelona, Spain.
  • Mòdol JM; Emergency Department, Hospital Universitari Germans Trias i Pujol de Badalona, Barcelona, Spain.
Eur J Emerg Med ; 27(6): 429-435, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32282468
OBJECTIVE: Amiodarone is a widely used drug in the emergency department (ED) for control of atrial fibrillation, but it has a delayed onset of action and slow metabolism, leading to longer length of ED stay. The aim of this study was to compare the length of ED stay of atrial fibrillation patients who were treated with or without amiodarone. METHODS: We undertook a multicenter, observational, cohort study of the URGFAICS registry of older adults with atrial fibrillation who presented to five Spanish EDs and compared patients who had received amiodarone with those who had not. Afterward, we performed a propensity score matched analysis of atrial fibrillation to determine the ED length of stay related to amiodarone. RESULTS: Of the 1199 patients included in the registry, 225 patients (18.8%) were treated with amiodarone while 974 (81.2%) were not. We performed a univariate study depending on amiodarone administration followed by propensity score calculation according to the 14 statistically different features found previously and six significant variables, obtaining 150 patients (75 for each group) suitable for the analysis. The length of ED stay was analyzed using box plot, with a P <0.001 in the crude analysis and P = 0.012 after propensity score matching and using survival curves for the analysis of prolonged ED stay, with a log rank <0.001 in the crude analysis and log rank 0.021 after the propensity score-matched analysis. CONCLUSION: Amiodarone is associated with longer length of ED stay until discharge independently of the baseline characteristics of the patients.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Servicio de Urgencia en Hospital / Amiodarona / Antiarrítmicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Eur J Emerg Med Asunto de la revista: MEDICINA DE EMERGENCIA Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Servicio de Urgencia en Hospital / Amiodarona / Antiarrítmicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Eur J Emerg Med Asunto de la revista: MEDICINA DE EMERGENCIA Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido